Mostrar el registro sencillo del ítem
Multifunctional nanocarriers for the treatment of periodontitis: Immunomodulatory, antimicrobial, and regenerative strategies
dc.contributor.author | Cafferata E.A. | |
dc.contributor.author | Alvarez C. | |
dc.contributor.author | Diaz K.T. | |
dc.contributor.author | Maureira M. | |
dc.contributor.author | Monasterio G. | |
dc.contributor.author | González F.E. | |
dc.contributor.author | Covarrubias C. | |
dc.contributor.author | Vernal R. | |
dc.date.accessioned | 2020-09-02T22:13:45Z | |
dc.date.available | 2020-09-02T22:13:45Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1111/odi.13023 | |
dc.identifier.citation | 25, 8, 1866-1878 | |
dc.identifier.issn | 1354523X | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/3863 | |
dc.description | Periodontitis is an inflammatory disease, in which the host immuno-inflammatory response against the dysbiotic subgingival biofilm leads to the breakdown of periodontal tissues. Most of the available treatments seem to be effective in the short-term; nevertheless, permanent periodical controls and patient compliance compromise long-term success. Different strategies have been proposed for the modulation of the host immune response as potential therapeutic tools to take a better care of most susceptible periodontitis patients, such as drug local delivery approaches. Though, maintaining an effective drug concentration for a prolonged period of time has not been achieved yet. In this context, advanced drug delivery strategies using biodegradable nanocarriers have been proposed to avoid toxicity and frequency-related problems of treatment. The versatility of distinct nanocarriers allows the improvement of their loading and release capabilities and could be potentially used for microbiological control, periodontal regeneration, and/or immunomodulation. In the present review, we revise and discuss the most frequent biodegradable nanocarrier strategies proposed for the treatment of periodontitis, including polylactic-co-glycolic acid (PLGA), chitosan, and silica-derived nanoparticles, and further suggest novel therapeutic strategies. © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved | |
dc.language.iso | en | |
dc.publisher | Blackwell Publishing Ltd | |
dc.subject | bioactive glass | |
dc.subject | chitosan | |
dc.subject | nanoparticles | |
dc.subject | periodontitis | |
dc.subject | PLGA | |
dc.subject | regulatory T lymphocytes | |
dc.subject | antiinfective agent | |
dc.subject | chitosan nanoparticle | |
dc.subject | mesoporous silica nanoparticle | |
dc.subject | nanocarrier | |
dc.subject | polyglactin | |
dc.subject | antiinfective agent | |
dc.subject | chitosan | |
dc.subject | nanoparticle | |
dc.subject | adaptive immunity | |
dc.subject | antimicrobial activity | |
dc.subject | drug delivery system | |
dc.subject | effective concentration | |
dc.subject | human | |
dc.subject | immunomodulation | |
dc.subject | innate immunity | |
dc.subject | nonhuman | |
dc.subject | patient compliance | |
dc.subject | periodontitis | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | tissue regeneration | |
dc.subject | chemistry | |
dc.subject | drug delivery system | |
dc.subject | periodontitis | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Anti-Infective Agents | |
dc.subject | Chitosan | |
dc.subject | Drug Delivery Systems | |
dc.subject | Humans | |
dc.subject | Nanoparticles | |
dc.subject | Periodontitis | |
dc.subject | Polylactic Acid-Polyglycolic Acid Copolymer | |
dc.title | Multifunctional nanocarriers for the treatment of periodontitis: Immunomodulatory, antimicrobial, and regenerative strategies | |
dc.type | Review |